 |
Size ($ in 1000's)
At 12/31/2023: $6,402,500
At 09/30/2023: $5,079,718
RA Capital Management L.P. holdings changes, total fund size, and other information presented on HoldingsChannel.com was derived from RA Capital Management L.P. 13F filings.
Link to 13F filings: SEC filings
|
|
|
As of 12/31/2023, below is a summary of the RA Capital Management L.P. top holdings by largest position size, as per the latest 13f filing made by RA Capital Management L.P..
In the RA Capital Management L.P.-top-holdings-table below, each of the top holdings by name is presented in the first column, followed by the amount of shares
held by RA Capital Management L.P. in that top holding, then the share count change between reporting periods, and finally the RA Capital Management L.P. top holding position size
for that row.
| Entity | Amount | Change
09/30/2023 to 12/31/2023 |
Position Size
($ in 1000's) |
|---|
| ASCENDIS PHARMA A S ADR |
10,107,400 |
-612,155 |
$1,273,027 | | ASND | 10,107,400 | -612,155 | $1,273,027 | | IMMUNOGEN INC |
23,750,601 |
+10,428,313 |
$704,205 | | IMGN | 23,750,601 | +10,428,313 | $704,205 | | VAXCYTE INC |
7,891,254 |
UNCH |
$495,571 | | PCVX | 7,891,254 | UNCH | $495,571 | | LEGEND BIOTECH CORP ADR |
6,264,707 |
UNCH |
$376,947 | | LEGN | 6,264,707 | UNCH | $376,947 | | RHYTHM PHARMACEUTICALS INC |
5,330,412 |
-345,655 |
$245,039 | | RYTM | 5,330,412 | -345,655 | $245,039 | | AEROVATE THERAPEUTICS INC |
8,263,982 |
UNCH |
$187,014 | | AVTE | 8,263,982 | UNCH | $187,014 | | INHIBRX INC |
4,724,207 |
UNCH |
$179,520 | | INBX | 4,724,207 | UNCH | $179,520 | | CYMABAY THERAPEUTICS INC |
6,940,000 |
UNCH |
$163,923 | | CBAY | 6,940,000 | UNCH | $163,923 | | BIOGEN INC |
532,892 |
UNCH |
$137,896 | | BIIB | 532,892 | UNCH | $137,896 | | RXSIGHT INC |
3,404,285 |
+351,489 |
$137,261 | | RXST | 3,404,285 | +351,489 | $137,261 | | 89BIO INC |
11,416,948 |
UNCH |
$127,527 | | ETNB | 11,416,948 | UNCH | $127,527 | | VERONA PHARMA PLC ADR |
6,317,990 |
UNCH |
$125,602 | | VRNA | 6,317,990 | UNCH | $125,602 | | DAY ONE BIOPHARMACEUTICALS I |
7,809,852 |
UNCH |
$114,024 | | DAWN | 7,809,852 | UNCH | $114,024 | | AN2 THERAPEUTICS INC |
5,551,295 |
UNCH |
$113,746 | | ANTX | 5,551,295 | UNCH | $113,746 | | TYRA BIOSCIENCES INC |
7,236,454 |
UNCH |
$100,225 | | TYRA | 7,236,454 | UNCH | $100,225 | | JANUX THERAPEUTICS INC |
9,165,652 |
UNCH |
$98,347 | | JANX | 9,165,652 | UNCH | $98,347 | | GERON CORP |
46,202,425 |
UNCH |
$97,487 | | GERN | 46,202,425 | UNCH | $97,487 | | ICOSAVAX INC |
5,963,565 |
UNCH |
$93,986 | | ICVX | 5,963,565 | UNCH | $93,986 | | ALPINE IMMUNE SCIENCES INC |
4,909,763 |
+218,585 |
$93,580 | | ALPN | 4,909,763 | +218,585 | $93,580 | | WAVE LIFE SCIENCES LTD |
18,202,009 |
+1,000,000 |
$91,920 | | WVE | 18,202,009 | +1,000,000 | $91,920 | | NEWAMSTERDAM PHARMA CO NV |
7,864,000 |
-1,136,000 |
$87,841 | | NAMS | 7,864,000 | -1,136,000 | $87,841 | | 4D MOLECULAR THERAPEUTICS IN |
4,163,211 |
UNCH |
$84,347 | | FDMT | 4,163,211 | UNCH | $84,347 | | EVOLENT HEALTH INC A |
2,549,132 |
-187,548 |
$84,198 | | EVH | 2,549,132 | -187,548 | $84,198 | | AXSOME THERAPEUTICS INC |
1,000,000 |
UNCH |
$79,590 | | AXSM | 1,000,000 | UNCH | $79,590 | | FULCRUM THERAPEUTICS INC |
11,609,704 |
UNCH |
$78,366 | | FULC | 11,609,704 | UNCH | $78,366 | | CYTEK BIOSCIENCES INC |
6,809,404 |
UNCH |
$62,102 | | CTKB | 6,809,404 | UNCH | $62,102 | | ACUMEN PHARMACEUTICALS INC |
14,932,063 |
UNCH |
$57,339 | | ABOS | 14,932,063 | UNCH | $57,339 | | PEPGEN INC |
8,131,952 |
UNCH |
$55,297 | | PEPG | 8,131,952 | UNCH | $55,297 | | APOGEE THERAPEUTICS INC |
1,977,901 |
UNCH |
$55,263 | | APGE | 1,977,901 | UNCH | $55,263 | | ARS PHARMACEUTICALS INC |
9,459,678 |
UNCH |
$51,839 | | SPRY | 9,459,678 | UNCH | $51,839 | | NKARTA INC |
7,805,129 |
UNCH |
$51,514 | | NKTX | 7,805,129 | UNCH | $51,514 | | VOR BIOPHARMA INC |
22,748,880 |
UNCH |
$51,185 | | VOR | 22,748,880 | UNCH | $51,185 | | ITEOS THERAPEUTICS INC |
4,417,259 |
UNCH |
$48,369 | | ITOS | 4,417,259 | UNCH | $48,369 | | MADRIGAL PHARMACEUTICALS INC |
204,500 |
UNCH |
$47,317 | | MDGL | 204,500 | UNCH | $47,317 | | UROGEN PHARMA LTD |
3,083,430 |
+1,599,733 |
$46,251 | | URGN | 3,083,430 | +1,599,733 | $46,251 | | MACROGENICS INC |
4,053,077 |
+3,711,077 |
$38,991 | | MGNX | 4,053,077 | +3,711,077 | $38,991 | | ELIEM THERAPEUTICS INC |
13,150,849 |
UNCH |
$35,507 | | ELYM | 13,150,849 | UNCH | $35,507 | | TAYSHA GENE THERAPIES INC |
18,472,503 |
UNCH |
$32,696 | | TSHA | 18,472,503 | UNCH | $32,696 | | GH RESEARCH PLC |
5,587,333 |
UNCH |
$32,407 | | GHRS | 5,587,333 | UNCH | $32,407 | | ENLIVEN THERAPEUTICS INC |
2,122,465 |
UNCH |
$29,375 | | ELVN | 2,122,465 | UNCH | $29,375 | | C4 THERAPEUTICS INC |
4,878,000 |
+4,878,000 |
$27,561 | | CCCC | 4,878,000 | +4,878,000 | $27,561 | | MINERALYS THERAPEUTICS INC |
3,178,476 |
UNCH |
$27,335 | | MLYS | 3,178,476 | UNCH | $27,335 | | WEREWOLF THERAPEUTICS INC |
6,144,881 |
UNCH |
$23,719 | | HOWL | 6,144,881 | UNCH | $23,719 | | ACRIVON THERAPEUTICS INC |
4,810,508 |
UNCH |
$23,668 | | ACRV | 4,810,508 | UNCH | $23,668 | | PLIANT THERAPEUTICS INC |
1,281,000 |
-481,000 |
$23,199 | | PLRX | 1,281,000 | -481,000 | $23,199 | | THIRD HARMONIC BIO INC |
2,033,056 |
+1,071,193 |
$22,303 | | THRD | 2,033,056 | +1,071,193 | $22,303 | | AVIDITY BIOSCIENCES INC |
2,454,533 |
-3,962,465 |
$22,214 | | RNA | 2,454,533 | -3,962,465 | $22,214 | | SOLID BIOSCIENCES INC |
3,426,286 |
UNCH |
$21,037 | | SLDB | 3,426,286 | UNCH | $21,037 | | STRUCTURE THERAPEUTICS INC |
486,832 |
+486,832 |
$19,843 | | GPCR | 486,832 | +486,832 | $19,843 | | TENAYA THERAPEUTICS INC |
5,507,347 |
-1,211,136 |
$17,844 | | TNYA | 5,507,347 | -1,211,136 | $17,844 |
See Full List: All Stocks Held By RA Capital Management L.P.
— Including:
• Biggest new positions
• Biggest exits
• Biggest increased positions
• Biggest decreased positions
See Details: Top 10 Stocks Held By RA Capital Management L.P.
|
|
